Efficacy Of Amalaki Ghanvati and Plaksha Yonivriti in Leucorrhoea

A Clinical Study Of Amalaki Ghanvati and Plaksha Yonivriti in the management of Shwetaprader(Excessive Vaginal discharge)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046815

Enrollment

100

Registered

2022-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N738- Other specified female pelvic inflammatory diseases Health Condition 2: N768- Other specified inflammation of vagina and vulva

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Married women patient having sign and symptoms of Shwetapradar

Exclusion criteria

Exclusion criteria: Unmarried women, patients suffering from VDRL, HIV, HTN and DM. Patients with any diagnosed uterine adnexal pathology and malignancy. Patients on hormonal therapy.

Design outcomes

Primary

Measure	Time frame
Efficacy of Amalaki Ghanvati and Plaksh Yonivarti in ShwetapradarTimepoint: 21 Days	—

Secondary

Measure	Time frame
To evaluate the effecacy of the drug in excessive vaginal discharges due to different- different micro-organism through high vaginal swab culture. To identify adverse effect if any.Timepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Vishnu Dutt Sharma

University Post Graduate Institute Of Ayurved Study & Research DSRRAU Jodhpur RAJASTHA

ayurvishnu@gmail.com7742042974

Outcome results